Neil K Warma

CIK 1437911 · Chief Executive Officer · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$64.0K

Companies

2

Total Filings

26

Lifetime Open-Market Net

$24.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
PMN	Chief Executive Officer	6,183	$10.35	$64.0K	$0	5	2026-05-22
Acer Therapeutics Inc. (OPXAW) Delisted	President, CEO and Acting CFO	144,881	—	—	$24.1K	21	2016-05-18

Recent Filings · Page 3 of 3

26 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2010-06-15	Acer Therapeutics Inc. (OPXAW) Delisted	Buy (P)	+8,000	$13.0K	EDGAR
2010-06-10	Acer Therapeutics Inc. (OPXAW) Delisted	Conv (C)	+21,213	$10.6K	EDGAR
2009-12-02	Acer Therapeutics Inc. (OPXAW) Delisted	Grant (A)	—	$0	EDGAR
2009-04-16	Acer Therapeutics Inc. (OPXAW) Delisted	Grant (A)	—	$0	EDGAR
2009-01-20	Acer Therapeutics Inc. (OPXAW) Delisted	Grant (A)	—	$0	EDGAR
2008-08-13	Acer Therapeutics Inc. (OPXAW) Delisted	Grant (A)	+3,021	$5.0K	EDGAR

Showing 21–26 of 26

Prev Page 3 of 3

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.